• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514

Comprehensive Overview of (5S)-5-(aminomethyl)pyrrolidin-2-one (CAS No. 145414-31-9)

(5S)-5-(aminomethyl)pyrrolidin-2-one, also known by its CAS number 145414-31-9, is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This chiral compound is characterized by its unique structural features, which include a pyrrolidine ring and an aminomethyl group, making it a valuable building block in the synthesis of various bioactive molecules.

The chemical structure of (5S)-5-(aminomethyl)pyrrolidin-2-one consists of a five-membered pyrrolidine ring with an amino group attached to the methyl side chain. This configuration imparts specific stereochemical properties that are crucial for its biological activity and reactivity in synthetic processes. The compound's chirality, denoted by the (5S) designation, plays a vital role in its interactions with biological targets, such as enzymes and receptors.

Recent advancements in the field of medicinal chemistry have highlighted the importance of (5S)-5-(aminomethyl)pyrrolidin-2-one in the development of novel therapeutic agents. For instance, studies have shown that this compound can serve as a key intermediate in the synthesis of peptidomimetics, which are designed to mimic the structure and function of natural peptides. These peptidomimetics have shown promise in various therapeutic areas, including cancer treatment, neurodegenerative diseases, and infectious diseases.

In the context of drug discovery, (5S)-5-(aminomethyl)pyrrolidin-2-one has been utilized to enhance the pharmacological properties of lead compounds. Its ability to improve solubility, stability, and bioavailability makes it an attractive candidate for optimizing drug candidates. Additionally, the compound's structural flexibility allows for the introduction of functional groups that can modulate its biological activity and binding affinity to target proteins.

One notable application of (5S)-5-(aminomethyl)pyrrolidin-2-one is in the development of inhibitors for specific enzymes involved in disease pathways. For example, researchers have synthesized derivatives of this compound that exhibit potent inhibitory activity against proteases and kinases, which are key targets in cancer and inflammatory diseases. These inhibitors have demonstrated significant efficacy in preclinical studies, paving the way for further clinical evaluation.

The synthesis of (5S)-5-(aminomethyl)pyrrolidin-2-one has been extensively studied, and several efficient routes have been developed to produce this compound on both laboratory and industrial scales. One common method involves the asymmetric hydrogenation of a prochiral precursor followed by selective functionalization steps to introduce the desired substituents. These synthetic strategies not only ensure high yields but also maintain the desired stereochemistry, which is critical for its biological applications.

In addition to its role as a synthetic intermediate, (5S)-5-(aminomethyl)pyrrolidin-2-one has been explored for its potential as a standalone therapeutic agent. Preclinical studies have shown that this compound exhibits neuroprotective effects by modulating signaling pathways involved in neuronal survival and function. These findings suggest that it could be developed into a novel treatment for neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.

The safety profile of (5S)-5-(aminomethyl)pyrrolidin-2-one has also been evaluated through various toxicological studies. Results indicate that it is generally well-tolerated at therapeutic doses, with minimal adverse effects observed in animal models. However, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.

In conclusion, (5S)-5-(aminomethyl)pyrrolidin-2-one (CAS No. 145414-31-9) is a highly versatile compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and stereochemical properties make it an invaluable tool for developing novel therapeutic agents targeting a wide range of diseases. Ongoing research continues to uncover new applications and optimize its use in drug discovery pipelines, underscoring its importance in advancing medical science.

• 219665-71-1(tetrahydro-Pyrrolo[3,2-b]pyrrole-2,5(1H,3H)-dione)
• 1262774-69-5(5-[(isopropylamino)methyl]-2-pyrrolidinone hydrochloride)
• 173336-98-6((5R)-5-(aminomethyl)pyrrolidin-2-one)
• 1210963-09-9(3,9-Diazabicyclo[4.2.1]nonan-4-one)
• 154148-69-3(5-Aminomethyl-pyrrolidin-2-one)
• 115307-13-6(5-(aminomethyl)pyrrolidin-2-one;hydrochloride)
• 1177316-08-3(5-{[(propan-2-yl)amino]methyl}pyrrolidin-2-one)
• 929972-85-0(5-(methylamino)methylpyrrolidin-2-one)
• 16308-48-8([2,2'-Bi-1H-azepine]-7,7'(2H,2'H)-dione, octahydro-)
• 1909294-11-6((5S)-5-(methylamino)methylpyrrolidin-2-one)